Thalidomide therapy clinical trial for chronic granulomatous disease-associated intractable granulomatous lesio
Not Applicable
- Conditions
- Chronic granulomatous disease
- Registration Number
- JPRN-UMIN000009370
- Lead Sponsor
- ational Center for Child Heath and Development
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 5
Inclusion Criteria
Not provided
Exclusion Criteria
a pregnant woman positive for HIV severe allegy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cure or mitigation of granulomatous lesion
- Secondary Outcome Measures
Name Time Method An effect on susceptibility to infection